Thermosensitive folic acid-targeted poly (ethylene-co-vinyl alcohol) hemisuccinate polymeric nanoparticles for delivery of epirubicin to breast cancer cells

被引:9
作者
Hassanzadeh, Farshid [1 ,2 ]
Maaleki, Sahar [2 ]
Varshosaz, Jaleh [1 ,3 ]
Khodarahmi, Ghadam Ali [2 ]
Farzan, Maryam [2 ]
Rostami, Mahboubeh [1 ,2 ]
机构
[1] Isfahan Univ Med Sci, Novel Drug Delivery Syst Res Ctr, Esfahan 8174673461, Iran
[2] Isfahan Univ Med Sci, Dept Med Chem, Sch Pharm, Esfahan 8174673461, Iran
[3] Isfahan Univ Med Sci, Dept Pharmaceut, Sch Pharm, Esfahan, Iran
关键词
Targeted polymeric nanoparticles; Thermosensitive; EVOH; Epirubicin (EPI); Breast cancer; DRUG-DELIVERY; IN-VITRO; SYSTEMS; RELEASE; DOXORUBICIN; THERAPY; VIVO; COMBINATION; RESISTANCE; LIPOSOMES;
D O I
10.1007/s13726-016-0483-z
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
A novel thermosensitive folic acid (FA)-targeted succinylated poly (ethylene-co-vinyl alcohol) (EVOH) (EVOHS-FA) nanocarrier was synthesized for the specific delivery of epirubicin (EPI) to MCF-7 breast cancer cell line. Three different ratios of synthesized EVOH-Suc were reacted with FA. The structure of the desired products (EVOHS40-FA, EVOHS60-FA and EVOHS80-FA) was confirmed by H-1 NMR and FTIR techniques. Nanoparticles were obtained by nano-precipitation procedure using DMSO/H2O as solvent/anti-solvent. The particle size, zeta potential, entrapment efficacy and in vitro release profile of the final formulations in different temperatures were measured. The optimized nanoparticles had the particle size of 214 +/- 8.5 nm, zeta potential of -29.6 mV, PDI of 0.198 +/- 0.04, and a high encapsulation efficiency that released the drug efficiently within 450 h at the temperature of 40 degrees C compared to 37 degrees C. The morphology of nanoparticles was studied by scanning electron microscopy. The in vitro cytotoxicity was evaluated using the MTT assay on MCF-7 cell lines in response to temperatures of 37 and 40 degrees C. The MTT assay indicated that the targeted nanoparticles carrying EPI were significantly more cytotoxic than the non-targeted nanoparticles and the free drug at 40 degrees C.
引用
收藏
页码:967 / 976
页数:10
相关论文
共 50 条
  • [31] Nanocarrier for Poorly Water-Soluble Anticancer Drugs-Barriers of Translation and Solutions
    Narvekar, Mayuri
    Xue, Hui Yi
    Eoh, June Young
    Wong, Ho Lun
    [J]. AAPS PHARMSCITECH, 2014, 15 (04): : 822 - 833
  • [32] Pacceti SD, 2004, Patent No. [US 20040054104 A1, 20040054104]
  • [33] Pan Xiaogang, 2004, Expert Opin Drug Deliv, V1, P7, DOI 10.1517/17425247.1.1.7
  • [34] Phan CM, 2004, J BIOMAT SCI-POLYM E, V25, P18
  • [35] Polymers in drug delivery
    Pillai, O
    Panchagnula, R
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (04) : 447 - 451
  • [36] Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review
    Rigon, Roberta Balansin
    Oyafuso, Marcia Helena
    Fujimura, Andressa Terumi
    Goncalez, Maria Lima
    do Prado, Alice Haddad
    Daflon Gremiao, Maria Palmira
    Chorilli, Marlus
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [37] Novel paclitaxel nanoparticles: Development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation
    Shavi, Gopal V.
    Kumar, A. Ranjith
    Karthik, A.
    Naseer, M.
    Aravind, G.
    Praful, B. D.
    Reddy, M. Sreenivasa
    Udupa, N.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2010, 148 (01) : E119 - E121
  • [38] Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development
    Sun, Wei-Liang
    Chen, Juan
    Wang, Yan-Ping
    Zheng, Hong
    [J]. AUTOPHAGY, 2011, 7 (09) : 1035 - 1044
  • [39] Localized delivery of doxorubicin in vivo from polymer-modified thermosensitive liposomes with MR-guided focused ultrasound-mediated heating
    Ta, Terence
    Bartolak-Suki, Elizabeth
    Park, Eun-Joo
    Karrobi, Kavon
    McDannold, Nathan J.
    Porter, Tyrone M.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2014, 194 : 71 - 81
  • [40] Takimoto CH., 2008, CANC MANAGEMENT MULT, V11